Cycurion (NASDAQ: CYCU) requests Nasdaq hearing on delisting
Rhea-AI Filing Summary
Cycurion, Inc. reported that it has requested a hearing before the Nasdaq Hearings Panel to appeal a July 10, 2026 delisting determination tied to the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(1). The hearing is scheduled to take place in August 2026.
The hearing request stays any suspension or delisting action during the hearing and any extension period, so Cycurion’s common stock is expected to continue trading on The Nasdaq Capital Market under the symbol “CYCU” at least through that time. The company plans to present a plan to regain and maintain compliance while continuing to operate its AI-driven cybersecurity solutions business.
Positive
- None.
Negative
- Cycurion received a Nasdaq delisting determination on July 10, 2026 for not meeting the minimum bid price under Nasdaq Listing Rule 5550(a)(1), placing its Nasdaq Capital Market listing at risk pending the outcome of an appeal hearing.
Insights
Analyzing...
8-K Event Classification
2 items: 8.01, 9.01
2 items
Item 8.01
Other Events
Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Key Figures
Nasdaq Listing Rule: Rule 5550(a)(1) minimum bid price requirement
Delisting determination date: July 10, 2026
Hearing timing: August 2026
+2 more
5 metrics
Nasdaq Listing Rule
Rule 5550(a)(1) minimum bid price requirement
Basis for Nasdaq’s July 10, 2026 delisting determination
Delisting determination date
July 10, 2026
Date Nasdaq issued delisting determination to Cycurion
Hearing timing
August 2026
Expected month of Cycurion’s hearing before the Nasdaq Hearings Panel
Press release date
July 22, 2026
Date Cycurion announced the scheduled Nasdaq listing hearing
Warrant exercise price
$345.00 per share
Exercise price of redeemable warrants trading under symbol CYCUW
Key Terms
Nasdaq Hearings Panel, minimum bid price requirement, Nasdaq Listing Rule 5550(a)(1), continued listing requirements, +1 more
5 terms
Nasdaq Hearings Panel regulatory
"requested a hearing before the Nasdaq Hearings Panel to appeal the delisting determination"
A Nasdaq hearings panel is a group of experts that reviews cases when a company's stock listing is at risk of being removed from the exchange. They evaluate whether the company has met certain standards and determine if it can keep trading on Nasdaq. This process matters to investors because it can affect a company's ability to raise money and maintain credibility in the market.
minimum bid price requirement regulatory
"relating to the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(1)"
A minimum bid price requirement is a rule that a stock must trade above a set price for a specified period to stay listed on an exchange. It matters to investors because falling below that threshold can trigger warnings or removal from the exchange, which can cut liquidity, reduce visibility, and often lead to sharper declines in share value—think of it like a venue’s minimum dress code that, if not met, can bar a performer from the stage.
Nasdaq Listing Rule 5550(a)(1) regulatory
"relating to the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(1)"
continued listing requirements regulatory
"ability to regain and maintain compliance with Nasdaq’s continued listing requirements"
Rules a stock exchange sets that a publicly traded company must keep meeting to stay listed and tradable on that exchange, such as minimum share price, market value, timely financial reports, and basic governance practices. Like a club’s membership rules, they matter because falling short can lead to warnings, penalties or removal from the exchange, which can cut liquidity, hurt share value and increase the risk for investors.
forward-looking statements regulatory
"This press release contains statements that are forward-looking statements as defined within the Private Securities Litigation Reform Act"
Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What did Cycurion (CYCU) announce about its Nasdaq listing status?
Cycurion announced it has requested a hearing before the Nasdaq Hearings Panel to appeal a July 10, 2026 delisting determination. The decision relates to Nasdaq’s minimum bid price requirement, and the company plans to present a compliance plan at the hearing.
Why is Cycurion (CYCU) facing a potential Nasdaq delisting?
Nasdaq issued Cycurion a delisting determination relating to the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(1). Cycurion is appealing this determination through a scheduled hearing and intends to outline how it will regain and maintain listing compliance.
When is Cycurion’s Nasdaq Hearings Panel session expected to occur?
The hearing before the Nasdaq Hearings Panel is expected to take place in August 2026. At that session, Cycurion plans to present its strategy to regain and maintain compliance with Nasdaq’s applicable listing standards, including the minimum bid price requirement.
What business does Cycurion (CYCU) operate while addressing Nasdaq issues?
Cycurion continues operating as an AI-driven cybersecurity solutions provider, offering cybersecurity, program management, and business continuity services. Using its AI-enhanced ARx platform and subsidiaries, it serves government, healthcare, and corporate clients while it works through the Nasdaq hearings process.
What securities of Cycurion are listed on Nasdaq and at what warrant price?
Cycurion lists its common stock under the symbol CYCU and redeemable warrants under CYCUW. Each warrant is exercisable for one share of common stock at an exercise price of $345.00 per share on The Nasdaq Stock Market.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): July 22, 2026
(Exact Name of Registrant as Specified in Its Charter)
| (State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) | ||||||||||||
(Address of principal executive offices) | (Zip Code) | |||||||||||||
Registrant’s telephone number, including area code: (888 ) 341-6680
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |||||
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |||||
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |||||
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) | |||||
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol | Name of each exchange on which registered | ||||||||||||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company x
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
Item 8.01 Other Events.
On July 22, 2026, the Company issued a press release. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
Item 9.01 Financial Statements and Exhibits
(d)Exhibits:
| Exhibit No. | Description | |||||||
| 99.1 | Press Release dated July 22, 2026 | |||||||
| 104 | Inline XBRL for the cover page of this Current Report on Form 8-K | |||||||
2
SIGNATURES
Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| CYCURION, INC. | ||||||||||||||
| Date: | July 24, 2026 | By: | /s/ L. Kevin Kelly | |||||||||||
| Name: | L. Kevin Kelly | |||||||||||||
| Title: | Chief Executive Officer | |||||||||||||
3
Exhibit 99.1
Cycurion, Inc. Announces Scheduled Nasdaq Listing Hearing and Reaffirms Commitment to Maintaining Nasdaq Listing
July 22, 2026
MCLEAN, Va., July 22, 2026 (GLOBE NEWSWIRE) -- Cycurion, Inc. (NASDAQ: CYCU) (“Cycurion” or the “Company”), a leading AI-driven, tech-enabled cybersecurity solutions provider, today announced that, as planned and previously disclosed, it requested a hearing before the Nasdaq Hearings Panel (the “Panel”) to appeal the delisting determination the Company received on July 10, 2026, relating to the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(1). The hearing has been scheduled and is expected to take place in August 2026.
The Company’s hearing request has stayed any suspension or delisting action pending the hearing and the expiration of any extension period that may be granted by the Panel following the hearing. Accordingly, the Company’s common stock is expected to continue to trade on The Nasdaq Capital Market under the symbol “CYCU” at least through that period.
At the hearing, the Company intends to present its plan to regain and maintain compliance with the applicable Nasdaq listing standards.
Cycurion continues to advance its core business operations while working through the Nasdaq hearings process.
About Cycurion, Inc.
Based in McLean, Virginia, Cycurion (NASDAQ: CYCU) is a forward-thinking provider of IT cybersecurity solutions and AI, committed to delivering secure, reliable, and innovative services to clients worldwide. Specializing in cybersecurity, program management, and business continuity, Cycurion harnesses its AI-enhanced ARx platform and expert team to empower clients and safeguard their operations. Along with its subsidiaries, Axxum Technologies LLC, Cloudburst Security LLC, and Cycurion Innovation, Inc., Cycurion serves government, healthcare, and corporate clients committed to securing the digital future. More info: www.cycurion.com.
Forward-Looking Statements
This press release contains statements that are forward-looking statements as defined within the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements relating to the operations and prospective growth of Cycurion’s business.
Certain statements in this press release that are not historical facts are forward-looking statements within the meaning of Section 27A of the Securities Exchange Act of 1934, as amended. Any statements contained in this press release that are not statements of historical fact may be deemed forward-looking statements. Such statements include, but are not limited to, the Company's appeal of Nasdaq's delisting determination; the outcome of the Company’s hearing before the Nasdaq Hearings Panel; the Company’s ability to regain and maintain compliance with Nasdaq’s continued listing requirements; the acceleration of the Company’s inorganic growth strategy through potential acquisitions and strategic transactions; the continued execution of the Company’s contracted backlog; and other statements that are not historical facts, including statements which may be accompanied by words such as “continue,” “will,” “may,” “could,” “should,” “expect,” “expected,” “plans,” “intend,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” and similar expressions intended to identify such forward-looking statements. All forward-looking statements involve significant risks and uncertainties that could cause actual results to differ materially from those expressed or implied in the forward-looking statements, many of which are generally outside
the control of Cycurion and are difficult to predict. Examples of such risks and uncertainties include, but are not limited to, the outcomes of the Company’s investigations, any potential legal proceedings, or the future performance of the Company’s stock. Additional factors that could cause actual results to differ materially from those expressed or implied in the forward-looking statements can be found in the most recent annual report on Form 10-K, quarterly reports on Form 10-Q, and current reports on Form 8-K filed by Cycurion with the U.S. Securities and Exchange Commission. Cycurion anticipates that subsequent events and developments may cause its plans, intentions, and expectations to change. Cycurion assumes no obligation, and it specifically disclaims any intention or obligation, to update any forward-looking statements, whether as a result of new information, future events, or otherwise, except as expressly required by law. Forward-looking statements speak only as of the date they are made and should not be relied upon as representing Cycurion’s plans and expectations as of any subsequent date.
Cycurion Investor Relations:
(888) 341-6680
investors@cycurion.com
Cycurion Media Relations:
(888) 341-6680
media@cycurion.com
2